목캔디 시장 예측(2026-2032년)

The Throat Lozenges Market is projected to grow by USD 6.31 billion at a CAGR of 5.11% by 2032.

Throat Lozenges Market Executive Summary

Throat lozenges are an established category within over-the-counter respiratory care, used to help soothe sore throat discomfort, support salivation, and deliver active or functional ingredients through slow oral dissolution. Demand is closely linked to seasonal respiratory infections, air pollution exposure, allergies, dry indoor environments, voice strain, and consumer preference for convenient self-care formats. The category spans medicated lozenges containing ingredients such as local anesthetics, antiseptics, demulcents, menthol, or herbal actives, as well as non-medicated and wellness-positioned products using honey, ginger, lemon, eucalyptus, zinc, vitamin C, and sugar-free formulations.

The throat lozenges landscape is shaped by public health guidance on responsible self-medication, evolving consumer expectations for clean-label ingredients, and rising use of pharmacy, grocery, convenience, and digital retail channels. Regulatory classification varies by formulation and jurisdiction, with some products treated as medicines, others as dietary supplements, and many as confectionery-style wellness products. This creates a competitive environment where ingredient claims, labeling compliance, taste, texture, format innovation, and trust in product safety are central to differentiation. As consumers increasingly seek accessible relief for minor throat irritation while avoiding unnecessary clinical visits, throat lozenges continue to hold relevance across both mature and emerging healthcare markets.

Transformative Shifts in the Throat Lozenges Landscape

The throat lozenges industry is undergoing transformative shifts driven by changing respiratory health behaviors, digital commerce adoption, and ingredient-led product innovation. Consumers are increasingly looking beyond basic symptom relief toward products that combine soothing benefits with natural positioning, sugar reduction, immunity support, and pleasant flavor profiles. This shift is encouraging greater use of botanical extracts, honey-based blends, pectin, menthol, eucalyptus, and functional nutrients, while also increasing demand for vegan, gluten-free, non-GMO, and artificial-color-free claims where local regulations allow.

Pharmacy-led recommendations remain influential, but omnichannel retail is reshaping product discovery. E-commerce platforms, quick-commerce delivery, and online pharmacy services have improved access to seasonal cough and sore throat remedies, particularly during influenza waves, COVID-19 surges, and periods of high air pollution. At the same time, consumers are becoming more label-aware, comparing active ingredients, dosage instructions, sugar content, and age suitability before purchase.

Manufacturers also face a more disciplined regulatory and quality environment. Claims related to antimicrobial action, immunity, pediatric use, and therapeutic relief require careful substantiation. Supply chains are adapting to volatility in sugar, glucose syrup, herbal raw materials, packaging inputs, and pharmaceutical-grade active ingredients. These shifts are moving the category toward evidence-supported claims, resilient sourcing, improved taste masking, and differentiated formats such as soft chews, hard lozenges, center-filled lozenges, and individually wrapped portable packs.

Cumulative Impact of Artificial Intelligence on Throat Lozenges

Artificial intelligence is becoming increasingly relevant across the throat lozenges value chain, particularly in consumer insight generation, formulation development, quality control, demand planning, and digital engagement. AI-enabled analytics can help identify seasonal search patterns related to sore throat, cough, flu, allergies, and dry throat symptoms, allowing producers and retailers to align inventory, promotions, and content with real-world consumer needs. This is especially useful because throat lozenge purchases often rise rapidly during cold and flu seasons, respiratory outbreaks, and air quality events.

In product development, AI can support faster screening of flavor combinations, sweetener systems, and ingredient interactions, helping formulators balance efficacy, mouthfeel, dissolution time, and sensory appeal. Machine learning can also assist with stability analysis and defect detection during production, improving batch consistency for medicated and non-medicated lozenges. In regulated segments, AI-supported document review and claim monitoring can help teams identify labeling risks, although human regulatory oversight remains essential.

AI is also influencing consumer education and retail personalization. Search engines, online marketplaces, and digital pharmacies increasingly use recommendation algorithms that shape visibility for throat lozenges based on symptoms, ingredient preferences, age groups, dietary restrictions, and purchase history. However, the cumulative impact of AI depends on responsible governance. Industry participants must ensure that AI-driven recommendations do not overstate therapeutic benefits, encourage inappropriate use, or blur distinctions between symptomatic relief and treatment of serious infections. The strongest outcomes will come from combining AI efficiency with verified product data, compliant claims, pharmacist guidance, and transparent consumer information.

Key Regional Insights for Throat Lozenges

Asia-Pacific represents a highly dynamic environment for throat lozenges, supported by large population bases, urban air pollution concerns, rising pharmacy access, and strong acceptance of herbal and traditional wellness ingredients. Markets in the region often show demand for menthol, honey, ginger, herbal, and cooling-sensation formats, while digital commerce and modern retail are expanding access in urban centers. North America is characterized by mature over-the-counter healthcare habits, strong seasonal demand during cold and flu periods, high awareness of sugar-free and functional formulations, and significant influence from pharmacy, mass retail, and online channels. Consumers in the region often evaluate throat lozenges based on active ingredients, flavor, brand trust, and compatibility with broader cough and cold regimens.

Latin America shows growing adoption of convenient sore throat relief products through pharmacies, supermarkets, and neighborhood retail, with demand influenced by changing weather patterns, urbanization, and consumer interest in affordable self-care. Europe is shaped by stringent product classification, labeling, and health-claim rules, creating a market environment where regulatory compliance, pharmacist involvement, and evidence-supported positioning are particularly important. Preferences vary across countries, but sugar-free, herbal, and medicated lozenges are widely present across pharmacy and retail channels.

The Middle East demonstrates demand linked to dry climate conditions, air-conditioned indoor environments, dust exposure, and high use of retail pharmacies. Product acceptance is influenced by halal suitability, flavor preferences, and trusted healthcare retail formats. Africa presents a developing landscape where throat lozenges are used across urban pharmacy and informal retail channels, with affordability, distribution reach, and product authenticity being critical considerations. Across all regions, the category benefits from its portability, immediate sensory relief, and compatibility with consumer-led self-care, while growth quality depends on regulatory discipline, reliable access, and responsible health communication.

Key Economic and Geopolitical Group Insights for Throat Lozenges

Within ASEAN, throat lozenges benefit from warm climates, high urban density, air pollution episodes, and consumer familiarity with herbal, honey, and menthol-based relief products. The region's expanding pharmacy networks, convenience stores, and mobile-first commerce ecosystem are improving product visibility, while local preferences often favor strong flavor, cooling sensation, and affordable pack sizes. In the GCC, demand is influenced by arid weather, dust exposure, widespread air-conditioning, and a consumer base that values pharmacy accessibility and premium wellness formats. Halal considerations, bilingual labeling, and flavor profiles aligned with regional preferences can be important for acceptance.

The European Union provides one of the most structured regulatory environments for throat lozenges, especially where products make medicinal, nutrition, or health claims. Compliance with medicine, food supplement, and food labeling frameworks is central to market access, and consumers often respond to sugar-free, herbal, and clinically familiar ingredients. BRICS countries collectively represent diverse opportunities and operational complexities, combining large populations, rising self-care adoption, strong local retail ecosystems, and varied regulatory pathways. Demand ranges from traditional herbal lozenges to medicated formulations, with affordability and distribution depth playing major roles.

G7 countries generally reflect mature consumer healthcare systems, high expectations for product safety, and strong retail infrastructure. In these markets, ingredient transparency, pediatric guidance, sugar reduction, and evidence-based claims support consumer trust. NATO member markets overlap significantly with North America and Europe, where pharmacy channels, defense-related public health preparedness, and cold-climate seasonal respiratory patterns contribute to steady awareness of cough and sore throat relief products. Across these groups, the most resilient strategies align formulation, claims, packaging, and channel execution with local health literacy, regulations, and self-care behaviors.

Key Country Insights for Throat Lozenges

In the United States, throat lozenges are embedded in over-the-counter cough, cold, and sore throat care, with consumers frequently purchasing through pharmacies, mass retailers, grocery outlets, convenience stores, and online platforms. Demand is shaped by seasonal respiratory illness, allergy periods, sugar-free preferences, and careful attention to active ingredient labeling. Canada reflects similar self-care behavior, with strong pharmacy relevance and consumer interest in products suited to cold winters, dry indoor heating, and bilingual labeling requirements. Mexico shows broad use of accessible sore throat remedies through pharmacies and modern retail, with affordability, flavor intensity, and trusted recommendations influencing purchase decisions.

Brazil demonstrates demand for convenient throat comfort products in urban markets, supported by pharmacy chains and consumer interest in herbal, honey, and menthol variants. The United Kingdom has a well-established consumer healthcare culture in which throat lozenges are commonly used for minor sore throat discomfort, with regulatory expectations around medicine claims and responsible use. Germany is characterized by high consumer scrutiny of ingredients, pharmacist influence, and acceptance of herbal and sugar-free formats. France places importance on pharmacy guidance, product quality, and carefully managed therapeutic claims, while Italy and Spain show demand linked to seasonal respiratory discomfort, voice strain, and preference for pleasant flavors and convenient packs. Russia has a strong tradition of pharmacy-based cough and cold care, with medicated and herbal lozenges used during cold seasons and periods of respiratory illness.

China represents a large and varied landscape where urban air quality concerns, traditional ingredient familiarity, e-commerce penetration, and pharmacy retail all influence throat lozenge demand. India shows strong relevance for affordable, widely distributed lozenges due to air pollution, seasonal infections, voice strain, and established acceptance of herbal ingredients such as ginger, honey, tulsi, and menthol-style cooling profiles. Japan is shaped by quality expectations, convenience retail, compact packaging, and consumer interest in functional, low-sugar, and soothing formats. Australia reflects demand from seasonal colds, allergies, dry environments, and pharmacy-led self-care, with clear labeling and product safety carrying importance. South Korea combines high digital retail adoption, strong beauty-and-wellness consumer culture, and interest in portable throat care products, especially among urban consumers exposed to fine dust and dry indoor air.

Actionable Recommendations for Throat Lozenges Industry Leaders

Industry leaders should prioritize evidence-supported formulation strategies that clearly distinguish medicated lozenges, wellness lozenges, dietary supplements, and confectionery-style throat comfort products. Claims should be aligned with the product's regulatory category and supported by appropriate documentation, especially for antiseptic, anesthetic, immunity, pediatric, and natural-origin positioning. Developing sugar-free, reduced-sugar, vegan, and clean-label options can address evolving consumer preferences, but taste, dissolution profile, and throat-coating sensation must remain central to repeat purchase.

Supply chain resilience should be strengthened through diversified sourcing of sweeteners, herbal extracts, flavor oils, packaging materials, and active pharmaceutical ingredients where applicable. Producers should invest in quality systems that ensure uniform active distribution, stability, moisture control, and packaging integrity. Retail strategies should be designed around seasonality, respiratory illness patterns, pollution events, and voice-use occasions such as teaching, performance, travel, and customer-facing work.

Digital execution is equally important. Brands and retailers should optimize educational content for high-intent search terms such as sore throat lozenges, cough drops, medicated throat lozenges, sugar-free throat lozenges, honey lozenges, menthol lozenges, and lozenges for dry throat. Online product pages should provide transparent ingredient information, usage directions, age restrictions, allergen details, and warnings for persistent symptoms. Collaboration with pharmacists and healthcare professionals can reinforce responsible self-care while reducing the risk of inappropriate claims. Leaders that combine compliant innovation, sensory excellence, accessible pricing, omnichannel availability, and trustworthy health communication will be better positioned to compete in the throat lozenges category.

Research Methodology for Throat Lozenges Analysis

A robust research methodology for analyzing throat lozenges should combine secondary research, primary stakeholder inputs, regulatory review, product benchmarking, and channel observation. Secondary research should examine public health guidance, over-the-counter medicine regulations, food and supplement labeling rules, pharmacopoeial references where relevant, respiratory illness seasonality, air quality data, and consumer health behavior studies. Regulatory analysis is essential because throat lozenges may be classified differently depending on ingredients, dosage, claims, and country-specific frameworks.

Primary research should include structured discussions with pharmacists, healthcare retailers, distributors, formulation specialists, regulatory professionals, packaging suppliers, and consumer health experts. Product benchmarking should compare active ingredients, excipients, flavors, sweetener systems, sugar-free claims, herbal positioning, pack sizes, usage instructions, warning labels, and price-tier architecture without relying on unsupported estimates. Channel research should evaluate pharmacy shelves, supermarkets, convenience stores, online marketplaces, quick-commerce platforms, and digital pharmacies to understand visibility, assortment depth, and consumer messaging.

Data validation should use triangulation across regulatory databases, product labels, public health sources, scientific literature, retail audits, and expert interviews. The methodology should exclude unsupported market sizing or speculative forecasting and instead focus on verifiable demand drivers, regulatory realities, innovation patterns, consumer preferences, and competitive positioning factors. This approach provides a reliable foundation for strategic decision-making in the throat lozenges industry.

Conclusion

Throat lozenges remain a practical and widely recognized self-care format for minor sore throat irritation, dry throat, and cough-related discomfort. The category's strength lies in its portability, fast sensory feedback, broad retail availability, and ability to accommodate both medicated and wellness-oriented formulations. Verified industry dynamics point to sustained relevance driven by seasonal respiratory illness, air pollution, allergy exposure, dry indoor environments, and consumer preference for accessible over-the-counter relief.

Future competitiveness will depend less on broad claims and more on credible differentiation. Successful participants will need to balance soothing efficacy, flavor appeal, compliant labeling, ingredient transparency, and channel availability. Regional and country-level variation will remain important, particularly in regulatory classification, preferred ingredients, climate-related demand, purchasing power, and pharmacy influence. Artificial intelligence can enhance formulation, demand sensing, and digital engagement, but it must be governed by accurate product information and responsible consumer guidance.

Overall, the throat lozenges industry is moving toward more informed self-care, cleaner ingredient expectations, omnichannel purchasing, and stricter claim accountability. Organizations that align innovation with verified consumer needs and regulatory requirements will be best positioned to build trust and relevance in this evolving respiratory care category.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Throat Lozenges Market, by Product Type

• 7.1. Introduction
• 7.2. Hard Lozenges
  • 7.2.1. Candy-Type
  • 7.2.2. Herbal drops
• 7.3. Soft Lozenges

8. Throat Lozenges Market, by Flavor

• 8.1. Introduction
• 8.2. Fruit
• 8.3. Honey
• 8.4. Mint

9. Throat Lozenges Market, by Ingredient

• 9.1. Introduction
• 9.2. Benzocaine Based
• 9.3. Herbal Extract Based
• 9.4. Menthol Based

10. Throat Lozenges Market, by End User

• 10.1. Introduction
• 10.2. Adult
• 10.3. Pediatric

11. Throat Lozenges Market, by Application

• 11.1. Introduction
• 11.2. Cough & Cold Relief
• 11.3. Mouth and Throat Infections
• 11.4. Sore Throat Relief

12. Throat Lozenges Market, by Distribution Channel

• 12.1. Introduction
• 12.2. Offline Channels
  • 12.2.1. Convenience Stores
  • 12.2.2. Pharmacies
  • 12.2.3. Supermarkets/Hypermarkets
• 12.3. Online Channels

13. Throat Lozenges Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Throat Lozenges Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Throat Lozenges Market, by Country

• 15.1. United States
• 15.2. China
• 15.3. India
• 15.4. Germany
• 15.5. Japan
• 15.6. United Kingdom
• 15.7. Canada
• 15.8. France
• 15.9. Australia
• 15.10. South Korea
• 15.11. Italy
• 15.12. Spain
• 15.13. Mexico
• 15.14. Brazil
• 15.15. Russia

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. FPNV Positioning Matrix, 2025
• 16.3. Market Concentration Analysis, 2025
  • 16.3.1. Concentration Ratio (CR)
  • 16.3.2. Herfindahl Hirschman Index (HHI)
• 16.4. Recent Developments & Impact Analysis, 2025
• 16.5. Product Portfolio Analysis, 2025
• 16.6. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Bliss GVS Pharma Ltd
• 17.2. Catalent, Inc. by Novo Holdings A/S
• 17.3. Church & Dwight Co., Inc.
• 17.4. Cipla Limited
• 17.5. Cloetta AB
• 17.6. Dabur Ltd.
• 17.7. Doetsch Grether AG
• 17.8. Dr. August Wolff GmbH & Co. KG Arzneimittel
• 17.9. Ernest Jackson Ltd.
• 17.10. Fisherman's Friend
• 17.11. G. R. Lane Health Products Ltd.
• 17.12. Gepach International
• 17.13. Haleon plc
• 17.14. Himalaya Wellness Company
• 17.15. Island Abbey Foods Ltd. by TopGum Industries, Ltd.
• 17.16. J. B. Chemicals & Pharmaceuticals Limited
• 17.17. Johnson & Johnson Services, Inc.
• 17.18. Lozen Pharma Pvt. Ltd
• 17.19. Mondelez International, Inc.
• 17.20. Opella Healthcare Group SAS
• 17.21. Perrigo Company plc
• 17.22. Pfizer Inc.
• 17.23. Piramal Group
• 17.24. Prestige Consumer Healthcare Inc.
• 17.25. Procter & Gamble Company
• 17.26. Reckitt Benckiser Group plc
• 17.27. Ricola AG
• 17.28. Traditional Medicinals, Inc.